Sanofi SANASDAQ:SNY
- LAST PRICE57.1300
- TODAY'S CHANGE (%)0.3800 (0.6696%)
- Bid / Lots54.0000/ 1
- Ask / Lots59.0000/ 1
- Open / Previous Close57.1200 / 56.7500
- Day Range
- 52 Week Range
- Volume2,186,160
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | SNY |
|---|---|---|
| 09:32 ET | 21483 | 57.09 |
| 09:34 ET | 8283 | 57.1 |
| 09:36 ET | 7572 | 57.08 |
| 09:38 ET | 82096 | 57.15 |
| 09:39 ET | 10422 | 57.16 |
| 09:41 ET | 14331 | 57.16 |
| 09:43 ET | 32851 | 57.175 |
| 09:45 ET | 6628 | 57.16 |
| 09:48 ET | 14226 | 57.16 |
| 09:50 ET | 7293 | 57.16 |
| 09:52 ET | 4973 | 57.17 |
| 09:54 ET | 9520 | 57.13 |
| 09:56 ET | 3260 | 57.11 |
| 09:57 ET | 2649 | 57.14 |
| 09:59 ET | 4341 | 57.12 |
| 10:01 ET | 7462 | 57.11 |
| 10:03 ET | 3501 | 57.11 |
| 10:06 ET | 3900 | 57.11 |
| 10:08 ET | 4741 | 57.06 |
| 10:10 ET | 1333 | 57.02 |
| 10:12 ET | 7611 | 57.011 |
| 10:14 ET | 5574 | 57.06 |
| 10:15 ET | 2801 | 57.09 |
| 10:17 ET | 12051 | 57.08 |
| 10:19 ET | 8973 | 57.03 |
| 10:21 ET | 6572 | 57.07 |
| 10:24 ET | 8884 | 57.05 |
| 10:26 ET | 9006 | 57.11 |
| 10:28 ET | 13256 | 57.15 |
| 10:30 ET | 8554 | 57.14 |
| 10:32 ET | 7800 | 57.14 |
| 10:33 ET | 10409 | 57.14 |
| 10:35 ET | 4261 | 57.12 |
| 10:37 ET | 11048 | 57.15 |
| 10:39 ET | 15042 | 57.2 |
| 10:42 ET | 21741 | 57.2 |
| 10:44 ET | 8702 | 57.2 |
| 10:46 ET | 24563 | 57.2 |
| 10:48 ET | 10563 | 57.195 |
| 10:50 ET | 9344 | 57.21 |
| 10:51 ET | 7082 | 57.2 |
| 10:53 ET | 7319 | 57.17 |
| 10:55 ET | 1701 | 57.17 |
| 10:57 ET | 11131 | 57.1702 |
| 11:00 ET | 5695 | 57.13 |
| 11:02 ET | 7558 | 57.09 |
| 11:04 ET | 7392 | 57.09 |
| 11:06 ET | 2025 | 57.06 |
| 11:08 ET | 9599 | 57 |
| 11:09 ET | 5603 | 57.01 |
| 11:11 ET | 6666 | 56.995 |
| 11:13 ET | 8554 | 56.98 |
| 11:15 ET | 800 | 56.94 |
| 11:18 ET | 9595 | 56.96 |
| 11:20 ET | 11509 | 56.995 |
| 11:22 ET | 7030 | 56.98 |
| 11:24 ET | 9472 | 57.04 |
| 11:26 ET | 4560 | 57.06 |
| 11:27 ET | 7348 | 57.05 |
| 11:29 ET | 8122 | 57.06 |
| 11:31 ET | 6470 | 57.09 |
| 11:33 ET | 9572 | 57.16 |
| 11:36 ET | 31694 | 57.21 |
| 11:38 ET | 12230 | 57.14 |
| 11:40 ET | 9280 | 57.175 |
| 11:42 ET | 5610 | 57.19 |
| 11:44 ET | 1557 | 57.13 |
| 11:45 ET | 1200 | 57.125 |
| 11:47 ET | 11042 | 57.22 |
| 11:49 ET | 31450 | 57.12 |
| 11:51 ET | 2086 | 57.13 |
| 11:54 ET | 5471 | 57.15 |
| 11:56 ET | 831 | 57.16 |
| 11:58 ET | 4784 | 57.155 |
| 12:00 ET | 1400 | 57.15 |
| 12:02 ET | 1100 | 57.145 |
| 12:03 ET | 1509 | 57.145 |
| 12:05 ET | 5357 | 57.1 |
| 12:07 ET | 3477 | 57.1101 |
| 12:09 ET | 1801 | 57.1 |
| 12:12 ET | 3311 | 57.105 |
| 12:14 ET | 200 | 57.1 |
| 12:16 ET | 1836 | 57.105 |
| 12:18 ET | 13894 | 57.105 |
| 12:20 ET | 9185 | 57.11 |
| 12:21 ET | 5524 | 57.08 |
| 12:23 ET | 2000 | 57.08 |
| 12:25 ET | 1015 | 57.0701 |
| 12:27 ET | 2483 | 57.085 |
| 12:30 ET | 1016 | 57.085 |
| 12:32 ET | 2051 | 57.08 |
| 12:34 ET | 3393 | 57.085 |
| 12:36 ET | 2396 | 57.08 |
| 12:38 ET | 1000 | 57.065 |
| 12:39 ET | 1105 | 57.065 |
| 12:41 ET | 3292 | 57.05 |
| 12:43 ET | 6691 | 57.03 |
| 12:45 ET | 1380 | 57.02 |
| 12:48 ET | 4744 | 57.055 |
| 12:50 ET | 1236 | 57.06 |
| 12:52 ET | 6470 | 57.055 |
| 12:54 ET | 1206 | 57.075 |
| 12:56 ET | 459 | 57.1 |
| 12:57 ET | 1305 | 57.1 |
| 12:59 ET | 1481 | 57.11 |
| 01:01 ET | 500 | 57.1 |
| 01:03 ET | 3740 | 57.14 |
| 01:06 ET | 16562 | 57.14 |
| 01:08 ET | 1593 | 57.125 |
| 01:10 ET | 1034 | 57.12 |
| 01:12 ET | 902 | 57.09 |
| 01:14 ET | 1246 | 57.105 |
| 01:15 ET | 2966 | 57.125 |
| 01:17 ET | 674 | 57.13 |
| 01:19 ET | 1204 | 57.135 |
| 01:21 ET | 400 | 57.135 |
| 01:24 ET | 500 | 57.14 |
| 01:26 ET | 1100 | 57.135 |
| 01:28 ET | 3440 | 57.14 |
| 01:30 ET | 2450 | 57.12 |
| 01:32 ET | 1300 | 57.125 |
| 01:33 ET | 25047 | 57.115 |
| 01:37 ET | 301 | 57.115 |
| 01:39 ET | 900 | 57.12 |
| 01:42 ET | 730 | 57.129 |
| 01:44 ET | 1312 | 57.12 |
| 01:46 ET | 300 | 57.125 |
| 01:48 ET | 1621 | 57.11 |
| 01:50 ET | 3024 | 57.11 |
| 01:51 ET | 6253 | 57.1011 |
| 01:53 ET | 631 | 57.105 |
| 01:55 ET | 1398 | 57.12 |
| 01:57 ET | 613 | 57.12 |
| 02:00 ET | 3910 | 57.115 |
| 02:02 ET | 1326 | 57.08 |
| 02:04 ET | 1643 | 57.08 |
| 02:06 ET | 2003 | 57.08 |
| 02:08 ET | 848 | 57.085 |
| 02:09 ET | 1686 | 57.1 |
| 02:11 ET | 400 | 57.11 |
| 02:13 ET | 1450 | 57.12 |
| 02:15 ET | 2999 | 57.145 |
| 02:18 ET | 1916 | 57.14 |
| 02:20 ET | 1025 | 57.135 |
| 02:22 ET | 554 | 57.13 |
| 02:24 ET | 1200 | 57.115 |
| 02:26 ET | 7032 | 57.09 |
| 02:27 ET | 1408 | 57.089 |
| 02:29 ET | 1945 | 57.07 |
| 02:31 ET | 918 | 57.075 |
| 02:33 ET | 1000 | 57.08 |
| 02:36 ET | 5500 | 57.09 |
| 02:38 ET | 2525 | 57.0875 |
| 02:40 ET | 593 | 57.095 |
| 02:42 ET | 1349 | 57.105 |
| 02:44 ET | 2321 | 57.13 |
| 02:45 ET | 3080 | 57.125 |
| 02:47 ET | 2700 | 57.125 |
| 02:49 ET | 2592 | 57.115 |
| 02:51 ET | 3596 | 57.115 |
| 02:54 ET | 3737 | 57.09 |
| 02:56 ET | 1114 | 57.08 |
| 02:58 ET | 400 | 57.085 |
| 03:00 ET | 2214 | 57.08 |
| 03:02 ET | 3549 | 57.07 |
| 03:03 ET | 10164 | 57.065 |
| 03:05 ET | 3365 | 57.04 |
| 03:07 ET | 4660 | 57.045 |
| 03:09 ET | 6262 | 57.0521 |
| 03:12 ET | 1071 | 57.05 |
| 03:14 ET | 4154 | 57.035 |
| 03:16 ET | 2439 | 57.02 |
| 03:18 ET | 6314 | 57.04 |
| 03:20 ET | 814 | 57.045 |
| 03:21 ET | 3453 | 57.045 |
| 03:23 ET | 886 | 57.04 |
| 03:25 ET | 7979 | 57.05 |
| 03:27 ET | 10824 | 57.055 |
| 03:30 ET | 1100 | 57.055 |
| 03:32 ET | 12836 | 57.055 |
| 03:34 ET | 5378 | 57.125 |
| 03:36 ET | 3595 | 57.14 |
| 03:38 ET | 1811 | 57.13 |
| 03:39 ET | 8380 | 57.115 |
| 03:41 ET | 5996 | 57.125 |
| 03:43 ET | 6826 | 57.115 |
| 03:45 ET | 13188 | 57.125 |
| 03:48 ET | 3072 | 57.125 |
| 03:50 ET | 16025 | 57.125 |
| 03:52 ET | 11434 | 57.125 |
| 03:54 ET | 18788 | 57.125 |
| 03:56 ET | 22672 | 57.095 |
| 03:57 ET | 41335 | 57.125 |
| 03:59 ET | 436200 | 57.13 |
Yesterday
DJ Regeneron, Sanofi Get FDA Approval for Upper Airway Disease Treatment, from 12:49PM ET on Friday Sep 13, 2024 by Dow Jones
12:49PM ET on Friday Sep 13, 2024 by Dow JonesDupixent(R) (dupilumab) Approved in the U.S. as First and Only Treatment for Adolescents with Chronic Rhinosinusitis with Nasal Polyps (CRSwNP), from 12:15PM ET on Friday Sep 13, 2024 by Dow Jones
12:15PM ET on Friday Sep 13, 2024 by Dow Jones
Sep 12, 2024
DJ Sanofi Teams Up With RadioMedix, Orano in $352 Mln Deal for Cancer Therapy -- Update, from 3:02AM ET on Thursday Sep 12, 2024 by Dow Jones
3:02AM ET on Thursday Sep 12, 2024 by Dow JonesDJ Sanofi Teams Up With RadioMedix, Orano in $352 Mln Deal for Cancer Therapy -- Update, from 3:02AM ET on Thursday Sep 12, 2024 by Dow Jones
3:02AM ET on Thursday Sep 12, 2024 by Dow JonesSanofi, RadioMedix, and Orano Med Announce Licensing Agreement on Next-Generation Radioligand Medicine for Rare Cancers, from 2:37AM ET on Thursday Sep 12, 2024 by Dow Jones
2:37AM ET on Thursday Sep 12, 2024 by Dow Jones
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Sanofi SA | 145.3B | 30.7x | +4.55% |
Pfizer Inc | 165.9B | -63.0x | -7.10% |
GSK plc | 88.9B | 16.7x | +6.39% |
Bristol-Myers Squibb Co | 99.6B | -15.1x | +4.90% |
Bayer AG | 29.4B | -21.0x | --- |
AstraZeneca PLC | 242.6B | 37.9x | +17.52% |
Company Information
Sanofi SA is a France-based healthcare company based in France. The Company focuses on patient needs and engages in the research, development, manufacture, and marketing of therapeutic solutions. Its three operating segments are: Pharmaceuticals, Consumer Healthcare (CHC), and Vaccines. The Pharmaceuticals includes: Immunology, Multiple Sclerosis / Neurology, Oncology, Rare Diseases, Rare Blood Disorders, Cardiovascular, Diabetes, Established Prescription Products. The Vaccines segment comprises, for all geographical territories, the commercial operations of Sanofi Pasteur, together with research, development, and production activities dedicated to vaccines. The CHC segment comprises the commercial operations for Sanofi’s Consumer Healthcare products, together with research, development and production activities dedicated to those products. The Company’s products developed in collaboration or franchise include Dupixent, Aubagio, Lemtrada, Cerezyme, Lumizyme, Jevtana, Fabrazyme.
Contact Information
- Headquarters
- 46 Avenue de la Grande ArmeePARIS, France 75017
- Phone
- ---
- Fax
- ---
Executives
- Independent Chairman of the Board
- Frederic Oudea
- Chief Executive Officer, Executive Director, Member of the Executive Committee
- Paul Hudson
- Chief Financial Officer, Member of the Executive Committee
- Francois-Xavier Roger
- Chief People Officer, Executive Vice President, Member of the Executive Committee
- Natalie Bickford
- Executive Vice President, General Counsel, Member of the Executive Committee
- Roy Papatheodorou
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $145.3B |
|---|---|
Revenue (TTM) | $52.5B |
Shares Outstanding | 2.5B |
Dividend Yield | 3.57% |
Annual Dividend Rate | 2.0369 USD |
Ex-Dividend Date | 05-09-24 |
Pay Date | 06-06-24 |
Beta | 0.57 |
EPS | $1.86 |
Book Value | $32.77 |
P/E Ratio | 30.7x |
Price/Sales (TTM) | 2.8 |
Price/Cash Flow (TTM) | 20.1x |
Operating Margin | 13.92% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
